摘要
目的探讨医院社区一体化的药学服务对支气管哮喘患者用药依从性和哮喘控制效果的影响。方法于2017年9月至2019年5月住院治疗的支气管哮喘患者180例,出院时随机分为干预组和对照组,各90例。干预组患者在出院后接受社区药师提供的医院社区一体化的药学服务,包括健康档案的创建、哮喘及用药知识的科普和吸入装置使用的指导等;对照组患者在出院后仅定期接受电话随访。于出院后1、6和12个月随访并比较哮喘控制测试(ACT)评分、肺功能、急性发作次数、用药依从性和吸入装置操作分数。结果干预组患者在出院后1、6和12个月的用药依从性和装置操作分数均明显高于对照组,出院后6和12个月肺功能指标高于对照组,出院后12个月ACT评分高于对照组,出院后12个月内急诊发作次数明显低于对照组(P<0.05)。结论医院社区一体化的药学服务模式不仅可使哮喘患者的用药依从性得到提高,而且哮喘控制水平得到明显改善,值得推广。
AIM To explore the effect of hospital community integrated pharmacy services on compliance and asthma control effects in patients with bronchial asthma.METHODS Totally 180 patients with bronchial asthma were divided into 2 groups randomly,with 90 patients in each group,receiving conventional treatment and pharmacy services in the hospital.The intervention group received hospital community integration pharmacy services after hospital discharge,including the creation of health records,popularization of asthma and medication knowledge and guidance on the use of inhalation devices,etc.and the control group received telephone follow-up.The 2 groups were compared in compliance,asthma control test(ACT)score,inhalation device operation score,pulmonary function indexes and acute attack times.RESULTS The medication compliance and device operation scores of patients in the intervention group were significantly higher than those in the control group at 1,6 and 12 months after discharge,lung function indexes at 6 and 12 months after discharge were higher than those in the control group,ACT score at 12 months after discharge was higher than those in the control group,and the number of emergency attacks at 12 months after discharge was significantly lower than that in the control group(P<0.05).CONCLUSION The hospital community integration pharmacy services management model can improve the compliance and asthma control level in asthma patients.It is a propagable pharmacy services model.
作者
谢宁
李曼
叶晓芬
XIE Ning;LI Man;YE Xiaofen(Department of Pharmacy,Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University,Shanghai 201700,China;Department of Pharmacy,Zhongshan Hospital Affiliated to Fudan University,Shanghai 200032,China)
出处
《中国临床药学杂志》
CAS
2022年第3期193-197,共5页
Chinese Journal of Clinical Pharmacy
基金
上海市临床药学重点专科建设项目(沪卫计药政[2018]9号)
上海市中西医结合学会科研基金(编号2020-30)
上海市青浦区学科带头人项目(编号WD2019-38)
上海市青浦区医苑新星项目(编号WY2019-23)
关键词
支气管哮喘
药学服务
医院社区一体化
bronchial asthma
community pharmacy services
hospitalcommunity integration
作者简介
第一作者:谢宁,副主任药师。研究方向:临床药学与药理学。E-mail:hisser@163.com;通信作者:叶晓芬,副主任药师。研究方向:临床药学与药理学。E-mail:ye.xiaofen@zs-hospital.sh.cn
